The Latest Cardiac and Vascular News
First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform DUBLIN, March 15, 2023 /PRNewswire/ — Medtronic (NYSE:MDT) announced today that it has received CE (Conformité Européenne) Mark for the Affera™ Mapping and Ablation System, which includes the Sphere-9™ […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first patients have been successfully treated in its PULSAR clinical study. The international, multicenter study recently received U.S. Food and […]
Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, today announced the strategic acquisition of substantially […]
First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years COPENHAGEN, Denmark, March 14, 2023 /PRNewswire/ — Acesion Pharma (“Acesion”), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation (“AF”), the most common cardiac arrhythmia, today announced positive data from its Phase 2 trial of […]
Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation Irvine, CA – March 7, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced […]
LONDON, March 07, 2023 (GLOBE NEWSWIRE) — Powerful Medical is thrilled to announce the release of PMcardio, a revolutionary clinical assistant powered by artificial intelligence in the United Kingdom. The unique medical device in the form of a smartphone application empowers healthcare professionals to diagnose and treat 38 cardiovascular diseases from […]
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, recently presented the results of multiple new […]
ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation DUBLIN and NEW ORLEANS, March 6, 2023 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field […]
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with HCM SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, a leader in AI-powered disease detection and care coordination, today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY), a global biopharmaceutical company, […]
Case studies highlighting vMap’s effectiveness at localizing arrhythmia termination sites in complex cases to be presented alongside vMap time study NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, developer of vMap® — the world’s first FDA-cleared technology to localize arrhythmias from just 12-lead ECG data — will present complex case studies that expand vMap’s utility […]
